Chain, Anne
Merck & Co., Inc., Rahway, NJ, USA (United States)
2 papers on CoChat
Most cited papers
- Verified
Immunogenicity of pembrolizumab in patients with advanced tumors
van Vugt, M. J. H., Stone, J. A., De Greef, “. H. J. M. M., Snyder, E. S., Lipka, L., Turner, D. C., Chain, A., Lala, M., Li, M., Robey, S. H., et al. (2019) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersBiosimilars and Bioanalytical Methods
Cited by 57
- Verified
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use
Nayak, S., Sander, O., Al‐Huniti, N., de Alwis, D., Chain, A., Chenel, M., Sunkaraneni, S., Agrawal, S., Gupta, N., & Visser, S. A. G. (2018) · Clinical Pharmacology & Therapeutics
Pharmaceutical studies and practicesStatistical Methods in Clinical Trials
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free